Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial.
- DOI
- 10.1016/j.metop.2026.100460
- Published
- 2026 Jun
- Container
- Metabolism open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.metop.2026.100460,
title = {Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial.},
author = {Sharma PK and Redkar SV and Madhav Karmalkar A and Anand S and Patil VS and Nurulhasan AR and Manan Bharatkumar P and Barge V and Shah SJ and Patel CB and Choudhary A and Sudheer K and Rambabu K and Narasinga Rao S and Swapna M and Ankathi SK and Singh VB and Sarkar G and Gautam SK and Das KK and Bhattacharya R and Tripathi KN and Sudarsi B and Parmar D and Kansagra K and Pathak H},
year = {2026},
journal = {Metabolism open},
doi = {10.1016/j.metop.2026.100460},
url = {https://doi.org/10.1016/j.metop.2026.100460}
}RIS
TY - JOUR TI - Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial. AU - Sharma PK AU - Redkar SV AU - Madhav Karmalkar A AU - Anand S AU - Patil VS AU - Nurulhasan AR AU - Manan Bharatkumar P AU - Barge V AU - Shah SJ AU - Patel CB AU - Choudhary A AU - Sudheer K AU - Rambabu K AU - Narasinga Rao S AU - Swapna M AU - Ankathi SK AU - Singh VB AU - Sarkar G AU - Gautam SK AU - Das KK AU - Bhattacharya R AU - Tripathi KN AU - Sudarsi B AU - Parmar D AU - Kansagra K AU - Pathak H PY - 2026 JO - Metabolism open DO - 10.1016/j.metop.2026.100460 UR - https://doi.org/10.1016/j.metop.2026.100460 ER -
APA
PK, S., SV, R., A, M. K., S, A., VS, P., AR, N., P, M. B., V, B., SJ, S., CB, P., A, C., K, S., K, R., S, N. R., M, S., SK, A., VB, S., G, S., SK, G., KK, D., R, B., KN, T., B, S., D, P., K, K., & H, P. (2026). Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial.. Metabolism open. https://doi.org/10.1016/j.metop.2026.100460
Source records
- pubmed · retrieved 2026-09-26T16:44:37.766Z